Company · CIK 0001439222 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AGIOS PHARMACEUTICALS, INC. · AGIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 SForm 4 → | Aug 6, 4:13 pm EDT | Sarah GheuensChief Medical Officer | 30,000 | $30.48 | $914,400 | 54,645 | −35.4% | 10b5-1 |
| Jul 8, 2026 AForm 4 → | Jul 10, 4:18 pm EDT | Jay T. BackstromDirector | 1,447 | — | — | 1,447 | — | |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:03 pm EDT | Sarah GheuensChief Medical Officer | 4,007 | $37.56 | $150,503 | 84,645 | −4.52% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 4:03 pm EDT | Sarah GheuensChief Medical Officer | 8,375 | — | — | 88,652 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 MForm 4 → | Jul 10, 4:18 pm EDT | Jay T. BackstromDirector | 1,447 | — | — | 2,894 | — | |
| Jul 1, 2026 MForm 4 → | Jul 2, 4:03 pm EDT | Sarah GheuensChief Medical Officer | 8,375 | — | — | 0 | — | 10b5-1 |